OK-432 sclerotherapy of lymphatic malformation in the head and neck: factors related to outcome
- 397 Downloads
No previous study to the best of our knowledge has examined the multiple factors related to the outcome of OK-432 sclerotherapy of lymphatic malformations.
This study aimed to assess factors related to the successful outcome of OK-432 sclerotherapy for lymphatic malformations in the head and neck region.
Materials and methods
During a 6-year period, OK-432 sclerotherapy was performed in 26 patients with lymphatic malformations. Several factors related to the efficacy of OK-432 sclerotherapy were evaluated, including the type (macrocystic or microcystic), the maximum lesion diameter, amount and hemorrhagic cytology of the aspirate, degree of aspiration, injected dose of OK-432 and post-therapy inflammation-related symptom. In all cases, ultrasound (US) follow-up was performed.
Of the 26 cases, 13 (50%) showed successful elimination of the lymphatic malformations in the follow-up US after the initial session, and all successful cases were of the macrocystic type. The type of lymphatic malformation and the success of OK-432 sclerotherapy were significantly related (P = 0.0149). Of the 16 cases of complete aspiration, 11 (68.8%) showed a successful outcome. Further, of the 17 cases with inflammation-related symptom, 13 (76.5%) showed a successful outcome. While the degree of aspiration and presence of inflammation-related symptom showed a significant relationship with the success of OK-432 sclerotherapy (P < 0.05), no other factors showed a significant relationship.
The study results suggest that the macrocystic type and complete aspiration of cystic contents were important factors for the success of OK-432 sclerotherapy of lymphatic malformations, and that inflammation-related symptom was a predictor of a successful outcome.
KeywordsHead and neck Lymphatic malformation OK-432 Sclerotherapy Ultrasound Child Adult
Conflict of interest
- 1.Hamoir M, Plouin-Gaudon I, Rombaux P et al (2001) Lymphatic malformations of the head and neck: a retrospective review and a support for staging. Head Neck 4:326–337Google Scholar
- 3.Banieghbal B, Davies MR (2003) Guidelines of the successful treatment of lymphangioma with OK-432. Eur J Pediatr Surg 2:103–107Google Scholar
- 5.Ogita S, Tsuto T, Tokiwa K et al (1987) Treatment of cystic hygroma in children with special reference to OK-432 therapy. Z kinderchir 5:279–281Google Scholar
- 6.Orvidas LJ, Kasperbauer JL (2000) Pediatric lymphangiomas of the head and neck. Ann Otol Rhinol Laryngol 4:411–421Google Scholar
- 9.Rautio R, Keski-Nisula L, Laranne J et al (2003) Treatment of lymphangiomas with OK-432 (Picibanil). Cardiovasc Intervent Radiol 1:31–36Google Scholar